Funviralpark Hababapa
The FDA is evaluating whether legal cannabis can be safely used in food, and the FDA will issue recommendations on how to regulate cannabis-derived products in the coming months. wall street journal Citing officials, it reported on Tuesday.
cannabis The plant contains multiple cannabinoid chemicals, including the non-psychoactive component cannabidiol or CBD, unlike the main psychoactive compound known as THC.
Patrick Culnoyer, who heads the FDA’s cannabis strategy as head of the Cannabis Products Commission, said the agency wanted to understand whether CBD is safe for long-term daily consumption or during pregnancy.
Manufacturers of products such as CBD oil currently operate without specific federal regulations governing production or marketing. The industry has not attracted large-scale investments because it is waiting for
The FDA has approved Epidiolex, a cannabidiol drug marketed by Jazz Pharmaceuticals (JAZZ), for a type of epilepsy.
“Given what we know to date about the safety of CBD, it raises concerns with the FDA as to whether these existing regulatory pathways in food and dietary supplements are suitable for this substance.” Former FDA Commissioner Janet Woodcock, who serves as the FDA’s chief deputy commissioner, was recently named chairman of the agency’s Cannabis Products Council.
The FDA currently regulates food products such as drugs, medical devices, dietary supplements, and infant formula. In recent years, the FDA has also extended its review of the manufacturing, distribution, and marketing of tobacco products.
US MSOs: MedMen Enterprises (OTCQB:MMNFF), Curaleaf Holdings (OTCPK:CURLF), Acreage Holdings (OTCQX:ACRHF), Cresco Labs (OTCQX:CRLBF), Green Thumb Industries (OTCQX:GTBIF), Trulieve Cannabis (OTCQX: TCNNF) ), Air Wellness (OTCQX: AYRWF), Columbia Cares (OTCQX: CCHWF), Terra Ascend (OTCQX: TRSSF), Clever Reeves Holdings (CLVR),
Licensed Producer in Canada: Canopy Growth (Nasdaq: CGC), Tilray (NASDAQ: TLRY), Chronos (Nasdaq: Kron), Aurora cannabis (NASDAQ: ACB), Sundial Growers (SNDL), OrganiGram Holdings (OGI), HEXO Corp (HEXO), Cronos Group (CRON)
Cannabis-focused ETFs: AdvisorShares Pure Cannabis ETF (YOLO), Global X Cannabis ETF (POTX), ETFMG Alternative Harvest ETF (MJ). Amplify Seymour Cannabis ETF (CNBS)
Read: In September, a panel in Japan’s Ministry of Health, Labor and Welfare recommended approval for the importation, manufacture and use of cannabis-derived medicines, applying the same regulatory process as pharmaceuticals.
